Outcome measure primary outcome
silicone foam
Cumulative incidence ratio will be calculated as a proportion of the difference between the number of sacral HAPI between the intervention and control groups (i.e. representing relative benefit). The difference in the risk of developing sacral HAPI within 14 days will be used to test the difference between the prophylactic silicone foam dressing and routine care.